Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.

patient reported outcome measures physiological prostatectomy prostatic neoplasms sexual dysfunction urinary incontinence

Journal

The Journal of urology
ISSN: 1527-3792
Titre abrégé: J Urol
Pays: United States
ID NLM: 0376374

Informations de publication

Date de publication:
Nov 2023
Historique:
pubmed: 11 8 2023
medline: 11 8 2023
entrez: 11 8 2023
Statut: ppublish

Résumé

Modifications to surgical technique, particularly the widespread adoption of robotic surgery, have been proposed to improve functional recovery after prostate cancer surgery. However, rigorous comparison of men in historical vs contemporary practice to evaluate the cumulative effect of these changes on urinary and sexual function after radical prostatectomy is lacking. We compared prospectively collected patient-reported urinary and sexual function from historical (PROSTQA [Prostate Cancer Outcomes and Satisfaction With Treatment Quality Assessment study], n=235) and contemporary (MUSIC-PRO [Michigan Urological Surgery Improvement Collaborative Patient Reported Outcome] registry, n=1,215) cohorts at the University of Michigan to understand whether modern techniques have resulted in functional improvements for men undergoing prostate cancer surgery. We found significant differences in baseline function, with better urinary (median [IQR]; 100 [93.8-100] vs 93.8 [85.5-100], Our results demonstrate that the widespread alterations in prostate cancer surgery over the past 2 decades have yielded improvements in sexual, but not urinary, function recovery.

Identifiants

pubmed: 37566643
doi: 10.1097/JU.0000000000003646
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

771-777

Commentaires et corrections

Type : CommentIn

Auteurs

Udit Singhal (U)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Department of Urology, Mayo Clinic, Rochester, Minnesota.

Brent K Hollenbeck (BK)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

Samuel D Kaffenberger (SD)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

Simpa S Salami (SS)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

Arvin K George (AK)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland.

Ted A Skolarus (TA)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Department of Surgery, University of Chicago, Chicago, Illinois.

Jeffrey S Montgomery (JS)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

Daniela A Wittmann (DA)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

David C Miller (DC)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

John T Wei (JT)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

Ganesh S Palapattu (GS)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

James E Montie (JE)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

Rodney L Dunn (RL)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

Todd M Morgan (TM)

Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.

Classifications MeSH